Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder P Abrams, KE Andersson, JJ Buccafusco, C Chapple, WC De Groat, ... British journal of pharmacology 148 (5), 565-578, 2006 | 707 | 2006 |
Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice T Rangasamy, J Guo, WA Mitzner, J Roman, A Singh, AD Fryer, ... The Journal of experimental medicine 202 (1), 47-59, 2005 | 688 | 2005 |
Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. DB Jacoby, GJ Gleich, AD Fryer The Journal of clinical investigation 91 (4), 1314-1318, 1993 | 415 | 1993 |
Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. AD Fryer, J Maclagan British journal of pharmacology 83 (4), 973, 1984 | 375 | 1984 |
Muscarinic acetylcholine receptors and airway diseases FR Coulson, AD Fryer Pharmacology & therapeutics 98 (1), 59-69, 2003 | 297 | 2003 |
Muscarinic receptors and control of airway smooth muscle AD Fryer, DB Jacoby American journal of respiratory and critical care medicine 158 (supplement_2 …, 1998 | 282 | 1998 |
Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea‐pig AD Fryer, DB Jacoby British journal of pharmacology 102 (1), 267-271, 1991 | 234 | 1991 |
Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function RW Costello, BH Schofield, GM Kephart, GJ Gleich, DB Jacoby, AD Fryer American Journal of Physiology-Lung Cellular and Molecular Physiology 273 (1 …, 1997 | 228 | 1997 |
Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection: eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor … DJ Adamko, BL Yost, GJ Gleich, AD Fryer, DB Jacoby The Journal of experimental medicine 190 (10), 1465-1478, 1999 | 204 | 1999 |
Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge AD Fryer, M Wills-Karp Journal of Applied Physiology 71 (6), 2255-2261, 1991 | 197 | 1991 |
Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD BC Moulton, AD Fryer British journal of pharmacology 163 (1), 44-52, 2011 | 174 | 2011 |
Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. CM Evans, AD Fryer, DB Jacoby, GJ Gleich, RW Costello The Journal of clinical investigation 100 (9), 2254-2262, 1997 | 173 | 1997 |
M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. LB Fernandes, AD Fryer, CA Hirshman Journal of Pharmacology and Experimental Therapeutics 262 (1), 119-126, 1992 | 171 | 1992 |
Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. LC Blaber, AD Fryer, J Maclagan British journal of pharmacology 86 (3), 723, 1985 | 162 | 1985 |
Eosinophil recruitment to the airway nerves DB Jacoby, RM Costello, AD Fryer Journal of allergy and clinical immunology 107 (2), 211-218, 2001 | 161 | 2001 |
Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. AD Fryer, DB Jacoby The Journal of clinical investigation 90 (6), 2292-2298, 1992 | 156 | 1992 |
Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung A Fryer, YC Huang, G Rao, D Jacoby, E Mancilla, R Whorton, ... Journal of Pharmacology and Experimental Therapeutics 282 (1), 208-219, 1997 | 150 | 1997 |
Muscarinic receptor antagonists: effects on pulmonary function KS Buels, AD Fryer Muscarinic Receptors, 317-341, 2012 | 142 | 2012 |
Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction AD Fryer, LH Stein, Z Nie, DE Curtis, CM Evans, ST Hodgson, PJ Jose, ... The Journal of clinical investigation 116 (1), 228-236, 2006 | 142 | 2006 |
β2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease BJ Proskocil, AD Fryer Proceedings of the American Thoracic Society 2 (4), 305-310, 2005 | 126 | 2005 |